ECNP Congress 2023 – References

References

  1. Howes OD, Rogdaki M, Findon JL, et al. Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. J Psychopharmacol. 2018;32(1):3-29. doi:10.1177/0269881117741766
  2. Johansson V, Sandin S, Chang Z, et al. Medications for attention-deficit/hyperactivity disorder in individuals with or without coexisting autism spectrum disorder: analysis of data from the Swedish prescribed drug register. J Neurodev Disord. 2020;12(1):44.
  3. Rodrigues R, Lai MC, Beswick A, Gorman DA, Anagnostou E, Szatmari P, Anderson KK, Ameis SH. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis. J Child Psychol Psychiatry. 2021 Jun;62(6):680-700.
  4. Joshi G, Wilens T, Firmin ES, Hoskova B, Biederman J. Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature. J Psychopharmacol. 2021;35(3):203-210.
  5. Muit JJ, Bothof N, Kan CC. Pharmacotherapy of ADHD in Adults With Autism Spectrum Disorder: Effectiveness and Side Effects. J Atten Disord. 2020;24(2):215-225.
  6. Perera G, Broadbent M, Callard F, et al. Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource. BMJ Open. 2016;6(3):e008721.

Author Contributions

The project was conceptualised by NA with input from GG. Study design was led by GG under supervision of NA, and facilitated by collaboration with the Maudsley BRC Clinical Records Interactive Search (CRIS) project team. Statistical analyses were conceived and designed by NA and performed by HH. The poster was written and designed by GG. All authors contributed to manuscript revision and read and approved the submitted version.

Funding

Study design and poster preparation were carried out during protected time as part of an NIHR Academic Clinical Fellowship post (Dr Gillett), although the project attracted no specific or additional grant or funding.

Ethical approval

The CRIS system has approval from the South Central – Oxford C Research Ethics Committee (ref: 18/SC/0372) and this study was approved by the CRIS Oversight Committee (ref: 22-083).